Institution
Fuyang Second People's Hospital
Recent research
- Health & MedicineOpen access
AIM: To compare the 1-year patency rates of drug-coated balloon (DCB) and drug-eluting stent (DES) in the treatment of lower extremity arteriosclerosis obliterans (LEASO), and to systematically analyze the factors influencing post-treatment patency.METHODS: This retrospective stu...
- Health & MedicineOpen access
Abstract Background Nutritional and metabolic abnormalities may contribute to adverse outcomes in dilated cardiomyopathy (DCM). The uric acid-to-albumin ratio (UAR), derived from two routinely measured biochemical parameters, may reflect this broader systemic burden. This study e...
- Health & MedicineOpen access
Femoral trochanteric fractures in older adults usually cause hip pain, but they may present atypically with acute immobility and no pain, leading to delayed diagnosis. We report an older patient in whom a painless femoral trochanteric fracture was initially misattributed to seque...
- Open access
Abstract Background Combined small‑cell lung carcinoma (C‑SCLC) is a rare heterogeneous lung malignancy prone to sampling‑related diagnostic errors. Limited tissue from percutaneous biopsy or intraoperative frozen sections may only capture inflammatory stroma instead of biphasic...
- Climate & Environment
Brodifacoum poisoning complicated by intestinal necrosis
Dear Editor,Brodifacoum is a potent, long-acting second-generation 4-hydroxycoumarin anticoagulant rodenticide that inhibits vitamin K epoxide reductase, impairing hepatic synthesis of coagulation ...
- Health & MedicineOpen access
Non-traditional lipid indices have been increasingly investigated as predictors of cardiovascular disease (CVD) risk, and frailty reflects cumulative physiological decline. Whether integrating these complementary dimensions improves CVD risk prediction remains unexplored. We aime...
- Health & MedicineOpen access
Neoadjuvant Anbenitamab and HB1801 in ERBB2 -Positive Breast Cancer
IMPORTANCE The combination of neoadjuvant taxanes with trastuzumab and pertuzumab remains the cornerstone treatment strategy in ERBB2 -positive breast cancer. Anbenitamab (a ERBB2 -biparatopic antibody that induces profound receptor clustering) and HB1801 (a solvent-free albumin-...
- Health & MedicineOpen access
Abstract Background Rectal cancer (RC) is a common and lethal malignant tumor, and surgical treatment is essential. The collateral system between the superior mesenteric artery (SMA) and inferior mesenteric artery (IMA) remains controversial, and its potential clinical significan...